General Information of Drug Transporter (DT)
DT ID DTD0271 Transporter Info
Gene Name SLC30A2
Transporter Name Zinc transporter 2
Gene ID
7780
UniProt ID
Q9BRI3
Post-Translational Modification of This DT
Overview of SLC30A2 Modification Sites with Functional and Structural Information
Sequence
PTM type
X-Phosphorylation X: Amino Acid

Phosphorylation

  Serine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Preventing the localization of transporters to lysosomes [1]

Role of PTM

Degradation via Lysosome

Modified Residue

Serine

Modified Location

296

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC30A2 Serine 296 have been reported to prevent its localization in the lysosome, thereby affecting its expression.

  Threonine

          2 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC30A2 [2]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

300

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC30A2 Threonine 300 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC30A2 [2]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

302

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC30A2 Threonine 302 has the potential to affect its expression or activity.
References
1 TNFalpha Post-Translationally Targets ZnT2 to Accumulate Zinc in Lysosomes. J Cell Physiol. 2015 Oct;230(10):2345-50.
2 Proteogenomics connects somatic mutations to signalling in breast cancer. Nature. 2016 Jun 2;534(7605):55-62.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.